Live Breaking News & Updates on Johnt henderson

Stay informed with the latest breaking news from Johnt henderson on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Johnt henderson and stay connected to the pulse of your community

Cytokinetics, Incorporated (NASDAQ:CYTK) Given Consensus Rating of "Moderate Buy" by Analysts

Shares of Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) have been given an average recommendation of “Moderate Buy” by the fifteen analysts that are presently covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average twelve-month […]

Maryland , United-states , America , Fady-ibraham-malik , Raymond-james , Johnt-henderson , Securities-exchange-commission , Quadrant-capital-group , Morgan-stanley , Cytokinetics-incorporated , Financial-services-group-inc , Mutual-of-america-capital-management

Cytokinetics, Incorporated (NASDAQ:CYTK) Shares Sold by Pinnacle Associates Ltd.

Cytokinetics, Incorporated (NASDAQ:CYTK) Shares Sold by Pinnacle Associates Ltd.
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

China , Roberti-blum , Raymond-james , Johnt-henderson , Cytokinetics-incorporated , Tower-group , Belpointe-asset-management , Morgan-stanley , Needham-company , Nasdaq , Chilton-capital-management , Pinnacle-associates-ltd

Mizuho Lowers Cytokinetics (NASDAQ:CYTK) Price Target to $99.00

Cytokinetics (NASDAQ:CYTK – Free Report) had its price objective lowered by Mizuho from $103.00 to $99.00 in a research note released on Wednesday morning, Benzinga reports. The brokerage currently has a buy rating on the biopharmaceutical company’s stock. CYTK has been the subject of a number of other reports. StockNews.com cut Cytokinetics from a hold […]

China , Fady-ibraham-malik , Johnt-henderson , Cytokinetics-incorporated , Belpointe-asset-management , China-universal-asset-management-co , Advisory-services-network , Cytokinetics-company-profile , Tower-group , Nasdaq , Morgan-stanley , Securities-exchange-commission

Mizuho Trims Cytokinetics (NASDAQ:CYTK) Target Price to $99.00

Cytokinetics (NASDAQ:CYTK – Free Report) had its target price decreased by Mizuho from $103.00 to $99.00 in a research report report published on Wednesday morning, Benzinga reports. Mizuho currently has a buy rating on the biopharmaceutical company’s stock. CYTK has been the topic of several other reports. B. Riley began coverage on Cytokinetics in a […]

China , Johnt-henderson , Tower-group , Belpointe-asset-management , China-universal-asset-management-co , Advisory-services-network , Needham-company , Cytokinetics-incorporated , Cytokinetics-company-profile , Free-report , Moderate-buy

Cytokinetics' (CYTK) "Buy" Rating Reaffirmed at HC Wainwright

Cytokinetics' (CYTK) "Buy" Rating Reaffirmed at HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Montreal , Quebec , Canada , Fady-ibraham-malik , Johnt-henderson , Advisor-group-holdings-inc , Jpmorgan-chase-co , Cytokinetics-incorporated , Securities-exchange-commission , Financial-services-group-inc , Raymond-james-associates , Free-report

Cytokinetics' (CYTK) "Buy" Rating Reaffirmed at HC Wainwright

HC Wainwright restated their buy rating on shares of Cytokinetics (NASDAQ:CYTK – Free Report) in a report issued on Friday, Benzinga reports. The firm currently has a $49.00 price target on the biopharmaceutical company’s stock. A number of other research firms have also recently commented on CYTK. StockNews.com upgraded Cytokinetics from a sell rating to […]

Montreal , Quebec , Canada , Fady-ibraham-malik , Johnt-henderson , Cytokinetics-incorporated , Jpmorgan-chase-co , Advisor-group-holdings-inc , Raymond-james-associates , Financial-services-group-inc , Securities-exchange-commission , Free-report

Cytokinetics (NASDAQ:CYTK) Upgraded to Hold by StockNews.com

StockNews.com upgraded shares of Cytokinetics (NASDAQ:CYTK – Free Report) from a sell rating to a hold rating in a research report released on Friday. Several other research firms also recently commented on CYTK. HC Wainwright reduced their price target on shares of Cytokinetics from $56.00 to $49.00 and set a buy rating on the stock […]

China , Fady-ibraham-malik , Johnt-henderson , Belpointe-asset-management , Goldman-sachs-group , Archer-investment-corp , Cytokinetics-incorporated , Cantor-fitzgerald , China-universal-asset-management-co , Fourthought-financial , Securities-exchange-commission , Free-report

Cytokinetics (NASDAQ:CYTK) Stock Rating Upgraded by StockNews.com

Cytokinetics (NASDAQ:CYTK – Free Report) was upgraded by investment analysts at StockNews.com from a “sell” rating to a “hold” rating in a note issued to investors on Friday. Other research analysts have also recently issued research reports about the stock. JPMorgan Chase & Co. raised their target price on shares of Cytokinetics from $52.00 to […]

United-states , China , America , Fady-ibraham-malik , Johnt-henderson , Nasdaq , Cantor-fitzgerald , Jpmorgan-chase-co , Goldman-sachs-group , Fourthought-financial , Cytokinetics-company-profile , Archer-investment-corp

Cytokinetics (NASDAQ:CYTK) Price Target Increased to $54.00 by Analysts at JPMorgan Chase & Co.

Cytokinetics (NASDAQ:CYTK – Get Rating) had its price objective boosted by JPMorgan Chase & Co. from $52.00 to $54.00 in a research report issued on Thursday, The Fly reports. JPMorgan Chase & Co.‘s price objective would indicate a potential upside of 49.50% from the company’s current price. Several other analysts also recently commented on the […]

Fady-ibraham-malik , Johnt-henderson , Jpmorgan-chase-co , Cytokinetics-incorporated , Cantor-fitzgerald , Prelude-capital-management , Geode-capital-management , Needham-company , Securities-exchange-commission , Saturnv-capital-management , Cytokinetics-company-profile

StockNews.com Upgrades Cytokinetics (NASDAQ:CYTK) to Hold

Cytokinetics (NASDAQ:CYTK – Get Rating) was upgraded by equities researchers at StockNews.com from a “sell” rating to a “hold” rating in a note issued to investors on Wednesday. CYTK has been the topic of a number of other reports. Oppenheimer dropped their price target on Cytokinetics from $55.00 to $54.00 and set an “outperform” rating […]

United-states , China , America , Fady-ibraham-malik , Johnt-henderson , Cytokinetics-inc , Fourthought-financial , Securities-exchange-commission , Goldman-sachs-group , China-universal-asset-management-co , Archer-investment-corp , Belpointe-asset-management